Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment.
about
Regulation of Natural Killer Cell Function by STAT3A multi-targeted approach to suppress tumor-promoting inflammationCXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer.CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasisExpression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma.EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway.Co-expressed differentially expressed genes and long non-coding RNAs involved in the celecoxib treatment of gastric cancer: An RNA sequencing analysis.A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome.Epigenetically silenced GNG4 inhibits SDF1α/CXCR4 signaling in mesenchymal glioblastomaTNF-α augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma.Metastatic site-specific polarization of macrophages in intracranial breast cancer metastases.Gene Expression Profiling of Chemokines and Their Receptors in Low and High Grade AstrocytomaRole of estrogen receptor alpha in human cervical cancer-associated fibroblasts: a transcriptomic study.Cell genomics and immunosuppressive biomarker expression influence PD-L1 immunotherapy treatment responses in HNSCC-a computational study.Transglutaminase type 2 affects cell migration through post-translational modification of platelet-derived growth factor-BB.Tailored chemokine receptor modification improves homing of adoptive therapy T cells in a spontaneous tumor model.Low-risk population among patients with tumor-node-metastasis stage III/IV oral squamous cell carcinoma.Evidence of lateral transmission of aggressive features between different types of breast cancer cellsUse of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal Adenocarcinoma.Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET.Adaptive Resistance to Cancer Immunotherapy.The RNA-binding protein HuR inhibits expression of CCL5 and limits recruitment of macrophages into tumors.Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies.Antibody Neutralization of CXCL10 in Vivo Is Dependent on Binding to Free and Not Endothelial-bound Chemokine: IMPLICATIONS FOR THE DESIGN OF A NEW GENERATION OF ANTI-CHEMOKINE THERAPEUTIC ANTIBODIES.Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.
P2860
Q26752551-4403C72A-A7F1-4CD1-9996-0BD834919DFBQ28393278-4AE5B9D9-7FFA-4573-A428-313C0AA57B95Q34537885-E59376D0-A6ED-43CA-BEC9-1EB8A489A4C1Q34654463-5DFC0669-BEA0-4E28-A33A-2C1334DFA6B5Q35848297-329CD537-5F6D-4BDC-A85A-98CE8310F239Q36026188-CA8127CA-D5FC-4257-9F02-D301A2E11D90Q36152244-05404AB0-59A2-45E8-AEBF-64C78C1F4ECBQ36929682-F4B8C69B-D72F-4AF6-8B2A-42CFAF013225Q37033314-57BB41F2-4088-4A49-94EE-7C86FC9FD6B2Q37370810-64BF549B-216D-4B1D-AD77-9638FFF9F9C2Q37520262-1307557E-ACB2-4004-967D-21E052551AE2Q38432528-3C95B495-FEDA-4D60-8B5D-8D439AEDA7F1Q38455904-EE83E461-BB22-4980-BC97-41FD19B47EBCQ38696133-946AF84C-E258-45AD-AE0A-635D4474B677Q38746075-D43D1FE6-AFA0-4BD8-9029-0F2611AD1385Q39985240-3FADB81E-9DD6-45C2-9EFD-FBFE526DA18EQ41619388-C3F78AE6-289A-4500-961F-84E6182BCDA5Q42378710-BDE24736-E677-452B-B5ED-E7A3D04BBC8AQ42776799-DE06EB15-3938-4F17-A4B2-5145EEDE8B87Q47100529-64A38E05-D47C-4C29-88D6-45D27C69D049Q47252744-D6B3FF73-6785-48B6-B4D0-EB15DA013B46Q48088391-20DDF1C1-BA56-48CC-8621-390663805615Q48308048-2920BCBF-D5A7-4659-9E3A-907DCC0A0186Q48847115-AB2BA5CB-7DF8-4BB9-A844-A04001563F43Q52682751-7C8B84A5-0B33-4516-A756-52CD278472A4
P2860
Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Chemokines in cancer developme ...... olecules for cancer treatment.
@en
type
label
Chemokines in cancer developme ...... olecules for cancer treatment.
@en
prefLabel
Chemokines in cancer developme ...... olecules for cancer treatment.
@en
P2860
P921
P356
P1476
Chemokines in cancer developme ...... olecules for cancer treatment.
@en
P2093
So-ichiro Sasaki
Tomohisa Baba
P2860
P304
P356
10.1155/2014/170381
P5008
P577
2014-05-22T00:00:00Z